Zimmer Biomet Holdings (ZBH) Stock Forecast & Price Target

Compare

1 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

ZBH Analyst Ratings

Moderate Buy

9 Buy

10 Hold

1 Sell

Based on 20 analysts giving stock ratings to

Zimmer

Biomet Holdings

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

ZBH Stock 12 Month Forecast

Average Price Target

CHF91.77

▲(12.60% Upside)

Based on 20 Wall Street analysts offering 12 month price targets for Zimmer Biomet Holdings in the last 3 months. The average price target is CHF91.77 with a high forecast of CHF111.72 and a low forecast of CHF77.72. The average price target represents a 12.60% change from the last price of CHF81.50.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"70":"CHF70","91":"CHF91","112":"CHF112","80.5":"CHF80.5","101.5":"CHF101.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":111.72135138,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">CHF111.72</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":91.7653273835,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">CHF91.77</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":77.71920096,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">CHF77.72</span>\n  </div></div>","useHTML":true}}],"tickPositions":[70,80.5,91,101.5,112],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2025","6":"Apr<br/>2025","9":"Jul<br/>2025","12":"Oct<br/>2025","25":"Oct<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,72,75.05548856769231,78.11097713538462,81.16646570307692,84.22195427076923,87.27744283846154,90.33293140615385,93.38841997384615,96.44390854153846,99.49939710923077,102.55488567692308,105.61037424461539,108.6658628123077,{"y":111.72135138,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,72,73.52040979873077,75.04081959746154,76.5612293961923,78.08163919492307,79.60204899365384,81.1224587923846,82.64286859111539,84.16327838984616,85.68368818857692,87.20409798730769,88.72450778603846,90.24491758476923,{"y":91.7653273835,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,72,72.43993853538461,72.87987707076923,73.31981560615384,73.75975414153847,74.19969267692308,74.63963121230769,75.0795697476923,75.51950828307692,75.95944681846153,76.39938535384616,76.83932388923077,77.27926242461538,{"y":77.71920096,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":108.091,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 31, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":108.091,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 23, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":108.091,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 24,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":108.308,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":108.308,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 26, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":108.308,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 26, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":108.519,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":108.519,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 23, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":108.519,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 20, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":108.71,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 16,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 27, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":71.809,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":71.809,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 24, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":72,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price TargetCHF111.72

Average Price TargetCHF91.77

Lowest Price TargetCHF77.72

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Lila Implantra

TR | OpenAI - 4o

CHF89.07

Buy

9.29%

Upside

Reiterated

10/30/25

AI Generated ArticleAI Generated Article

Caitlin Cronin

Canaccord Genuity

CHF80.32

Hold

-1.44%

Downside

Reiterated

10/21/25

Canaccord Genuity Sticks to Their Hold Rating for Zimmer Biomet Holdings (ZBH)

Ryan Zimmerman

BTIG

CHF93.84→CHF97.03

Buy

19.05%

Upside

Reiterated

10/13/25

Zimmer Biomet price target raised to $122 from $118 at BTIGZimmer Biomet price target raised to $122 from $118 at BTIG

Matthew O'Brien

Piper Sandler

―

Hold

―

Reiterated

10/13/25

Piper Sandler Keeps Their Hold Rating on Zimmer Biomet Holdings (ZBH)

Shagun Singh Chadha

RBC Capital

CHF91.46→CHF88.28

Buy

8.32%

Upside

Reiterated

10/10/25

Zimmer Biomet price target lowered to $111 from $115 at RBC CapitalZimmer Biomet price target lowered to $111 from $115 at RBC Capital

Vijay Kumar

Evercore ISI

CHF84.3→CHF82.71

Hold

1.48%

Upside

Reiterated

10/07/25

Evercore ISI Sticks to Their Hold Rating for Zimmer Biomet Holdings (ZBH)

Danielle Antalffy

UBS

CHF76.35

Sell

-6.32%

Downside

Reiterated

10/06/25

Zimmer Biomet Holdings (ZBH) Gets a Sell from UBS

Rick Wise

Stifel Nicolaus

CHF91.46→CHF93.84

Buy

15.15%

Upside

Reiterated

09/19/25

Stifel Nicolaus Remains a Buy on Zimmer Biomet Holdings (ZBH)

Ed Ridley-Day

Rothschild & Co Redburn

CHF103.39

Buy

26.86%

Upside

Initiated

09/18/25

Zimmer Biomet Holdings (ZBH) Initiated with a Buy at Redburn Atlantic

Travis Steed

Bank of America Securities

CHF87.48

Hold

7.34%

Upside

Reiterated

09/08/25

Zimmer Biomet Holdings: Stable Performance with Limited Growth Prospects Justifies Hold Rating

Lee Hambright

Bernstein

CHF83.51

Hold

2.46%

Upside

Reiterated

09/08/25

Bernstein Remains a Hold on Zimmer Biomet Holdings (ZBH)

Patrick Wood

Morgan Stanley

CHF79.53

Hold

-2.42%

Downside

Reiterated

09/08/25

Zimmer Biomet Holdings: Operational Improvements and Strategic Positioning Amid Cautious Growth Prospects

David Turkaly

Citizens JMP

CHF99.41

Buy

21.98%

Upside

Reiterated

08/20/25

Citizens JMP Keeps Their Buy Rating on Zimmer Biomet Holdings (ZBH)

Richard Newitter

Truist Financial

―

Hold

―

Reiterated

08/08/25

Analysts Offer Insights on Healthcare Companies: Zimmer Biomet Holdings (NYSE: ZBH) and Crinetics Pharmaceuticals (NASDAQ: CRNX)

Jayson Bedford

Raymond James

CHF82.71→CHF89.87

Buy

10.27%

Upside

Reiterated

08/08/25

Zimmer Biomet price target raised to $113 from $104 at Raymond JamesZimmer Biomet price target raised to $113 from $104 at Raymond James

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Lila Implantra

TR | OpenAI - 4o

CHF89.07

Buy

9.29%

Upside

Reiterated

10/30/25

AI Generated ArticleAI Generated Article

Caitlin Cronin

Canaccord Genuity

CHF80.32

Hold

-1.44%

Downside

Reiterated

10/21/25

Canaccord Genuity Sticks to Their Hold Rating for Zimmer Biomet Holdings (ZBH)

Ryan Zimmerman

BTIG

CHF93.84→CHF97.03

Buy

19.05%

Upside

Reiterated

10/13/25

Zimmer Biomet price target raised to $122 from $118 at BTIGZimmer Biomet price target raised to $122 from $118 at BTIG

Matthew O'Brien

Piper Sandler

―

Hold

―

Reiterated

10/13/25

Piper Sandler Keeps Their Hold Rating on Zimmer Biomet Holdings (ZBH)

Shagun Singh Chadha

RBC Capital

CHF91.46→CHF88.28

Buy

8.32%

Upside

Reiterated

10/10/25

Zimmer Biomet price target lowered to $111 from $115 at RBC CapitalZimmer Biomet price target lowered to $111 from $115 at RBC Capital

Vijay Kumar

Evercore ISI

CHF84.3→CHF82.71

Hold

1.48%

Upside

Reiterated

10/07/25

Evercore ISI Sticks to Their Hold Rating for Zimmer Biomet Holdings (ZBH)

Danielle Antalffy

UBS

CHF76.35

Sell

-6.32%

Downside

Reiterated

10/06/25

Zimmer Biomet Holdings (ZBH) Gets a Sell from UBS

Rick Wise

Stifel Nicolaus

CHF91.46→CHF93.84

Buy

15.15%

Upside

Reiterated

09/19/25

Stifel Nicolaus Remains a Buy on Zimmer Biomet Holdings (ZBH)

Ed Ridley-Day

Rothschild & Co Redburn

CHF103.39

Buy

26.86%

Upside

Initiated

09/18/25

Zimmer Biomet Holdings (ZBH) Initiated with a Buy at Redburn Atlantic

Travis Steed

Bank of America Securities

CHF87.48

Hold

7.34%

Upside

Reiterated

09/08/25

Zimmer Biomet Holdings: Stable Performance with Limited Growth Prospects Justifies Hold Rating

Lee Hambright

Bernstein

CHF83.51

Hold

2.46%

Upside

Reiterated

09/08/25

Bernstein Remains a Hold on Zimmer Biomet Holdings (ZBH)

Patrick Wood

Morgan Stanley

CHF79.53

Hold

-2.42%

Downside

Reiterated

09/08/25

Zimmer Biomet Holdings: Operational Improvements and Strategic Positioning Amid Cautious Growth Prospects

David Turkaly

Citizens JMP

CHF99.41

Buy

21.98%

Upside

Reiterated

08/20/25

Citizens JMP Keeps Their Buy Rating on Zimmer Biomet Holdings (ZBH)

Richard Newitter

Truist Financial

―

Hold

―

Reiterated

08/08/25

Analysts Offer Insights on Healthcare Companies: Zimmer Biomet Holdings (NYSE: ZBH) and Crinetics Pharmaceuticals (NASDAQ: CRNX)

Jayson Bedford

Raymond James

CHF82.71→CHF89.87

Buy

10.27%

Upside

Reiterated

08/08/25

Zimmer Biomet price target raised to $113 from $104 at Raymond JamesZimmer Biomet price target raised to $113 from $104 at Raymond James

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Zimmer Biomet Holdings

1 Month

xxx

Success Rate

14/23 ratings generated profit

Average Return

+1.07%

reiterated a xxx

rating 26 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 60.87% of your transactions generating a profit, with an average return of +1.07% per trade.

3 Months

xxx

Success Rate

27/45 ratings generated profit

Average Return

+2.37%

assigned a xxx

rating a year ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 60.00% of your transactions generating a profit, with an average return of +2.37% per trade.

1 Year

Rick WiseStifel Nicolaus

Success Rate

16/30 ratings generated profit

Average Return

+4.45%

reiterated a buy rating 2 months ago

Copying Rick Wise's trades and holding each position for 1 Year would result in 58.62% of your transactions generating a profit, with an average return of +4.45% per trade.

2 Years

xxx

Success Rate

25/45 ratings generated profit

Average Return

+5.64%

assigned a xxx

rating a year ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 55.56% of your transactions generating a profit, with an average return of +5.64% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

ZBH Analyst Recommendation Trends

Rating

Jun 25

Jul 25

Aug 25

Sep 25

Oct 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, ZBH has received 20 Buy Ratings, 17 Hold Ratings, and 2 Sell Ratings. ZBH average Analyst price target in the past 3 months is 91.77.

Each month's total comprises the sum of three months' worth of ratings.

ZBH Financial Forecast

ZBH Earnings Forecast

Next quarter’s earnings estimate for ZBH is CHF1.51 with a range of CHF1.46 to CHF1.58. The previous quarter’s EPS was CHF1.68. ZBH beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.09% of the time in the same period. In the last calendar year ZBH has Preformed in-line its overall industry.

ZBH Sales Forecast

Next quarter’s sales forecast for ZBH is CHF1.63B with a range of CHF1.61B to CHF1.64B. The previous quarter’s sales results were CHF1.68B. ZBH beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.55% of the time in the same period. In the last calendar year ZBH has Preformed in-line its overall industry.

ZBH Stock Forecast FAQ

What is CH:ZBH’s average 12-month price target, according to analysts?

Based on analyst ratings, Zimmer Biomet Holdings’s 12-month average price target is 91.77.

What is CH:ZBH’s upside potential, based on the analysts’ average price target?

Zimmer Biomet Holdings has 12.60% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Zimmer Biomet Holdings a Buy, Sell or Hold?

Zimmer Biomet Holdings has a consensus rating of Moderate Buy, which is based on 9 buy ratings, 10 hold ratings and 1 sell ratings.

What is Zimmer Biomet Holdings’s share price target?

The average share price target for Zimmer Biomet Holdings is 91.77. This is based on 20 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is CHF111.72 ,and the lowest forecast is CHF77.72. The average share price target represents 12.60% Increase from the current price of CHF81.5.

What do analysts say about Zimmer Biomet Holdings?

Zimmer Biomet Holdings’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 20 Wall Streets Analysts.

How can I buy shares of Zimmer Biomet Holdings?

To buy shares of CH:ZBH, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Zimmer Biomet Holdings (ZBH) Stock Forecast & Price Target

ZBH Analyst Ratings

ZBH Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Zimmer Biomet Holdings

ZBH Analyst Recommendation Trends

ZBH Financial Forecast

ZBH Earnings Forecast

ZBH Sales Forecast

ZBH Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts